SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart

Ven Gee Lim, RM Bell, Sapna Arjun, Maria Kolatsi‐Joannou, David A. Long, Derek M. Yellon

Journal of Molecular and Cellular Cardiology · 2018 · 26 citations · 0 references

Concepts